Your browser doesn't support javascript.
loading
Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications.
Andersen, Peter M; Kuzma-Kozakiewicz, Magdalena; Keller, Jürgen; Aho-Oezhan, Helena E A; Ciecwierska, Katarzyna; Szejko, Natalia; Vázquez, Cynthia; Böhm, Sarah; Badura-Lotter, Gisela; Meyer, Thomas; Petri, Susanne; Linse, Katharina; Hermann, Andreas; Semb, Olof; Stenberg, Erica; Nackberg, Simona; Dorst, Johannes; Uttner, Ingo; Häggström, Ann-Cristin; Ludolph, Albert C; Lulé, Dorothée.
Affiliation
  • Andersen PM; Institute of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
  • Kuzma-Kozakiewicz M; Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
  • Keller J; Neurodegenerative Diseases Research Group, Medical University of Warsaw, Warsaw, Poland.
  • Aho-Oezhan HEA; Department of Neurology, University of Ulm, Ulm, Germany.
  • Ciecwierska K; Department of Neurology, University of Ulm, Ulm, Germany.
  • Szejko N; Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
  • Vázquez C; Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
  • Böhm S; Department of Neurology, University of Ulm, Ulm, Germany.
  • Badura-Lotter G; Department of Neurology, University of Ulm, Ulm, Germany.
  • Meyer T; Department of History and Ethics of Medicine, University of Ulm, Ulm, Germany.
  • Petri S; Department of Neurology, Charité CVK, Berlin, Germany.
  • Linse K; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Hermann A; Department of Neurology, Technische Universität Dresden, Germany and German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany.
  • Semb O; Department of Neurology, Technische Universität Dresden, Germany and German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany.
  • Stenberg E; Department of Clinical Science, Umeå University, Umeå, Sweden.
  • Nackberg S; Institute of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
  • Dorst J; Department of Clinical Science, Umeå University, Umeå, Sweden.
  • Uttner I; Department of Neurology, University of Ulm, Ulm, Germany.
  • Häggström AC; Department of Neurology, University of Ulm, Ulm, Germany.
  • Ludolph AC; Institute of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
  • Lulé D; Department of Neurology, University of Ulm, Ulm, Germany. albert.ludolph@rku.de.
J Neurol ; 265(7): 1600-1606, 2018 Jul.
Article in En | MEDLINE | ID: mdl-29728768
ABSTRACT

OBJECTIVE:

Quantitative analysis of decision-making on therapeutic options in different sociocultural context in amyotrophic lateral sclerosis (ALS).

METHODS:

ALS patients (n = 244) were consecutively recruited in Germany (n = 83), Poland (n = 83), and Sweden (n = 78) in a prospective cross-cultural study ( www.NEEDSinALS.com ). They were interviewed on preferences for therapeutic techniques including invasive (IV) and non-invasive ventilation (NIV), as well as percutaneous endoscopic gastrostomy (PEG) and on hypothetical termination of these using quantitative questions. Using standardized questionnaires, religiousness, personal values, quality of life, and depressiveness were assessed.

RESULTS:

NIV was most frequently used in Germany and PEG in Sweden. Swedish patients were most liberal on initiation and termination of PEG, NIV and IV. Polish patients were mostly undecided and were least likely to consider discontinuing supportive management. Current use was partly associated with age, gender and state of physical function; also, financial support explained some variance. Future preferences on therapeutic options from the patient's perspective were also closely associated with cultural factors. The more oriented towards traditional and conservative values, the less likely patients were to decide for invasive therapeutic devices (IV, PEG), the least likely to have ideations to discontinue any device and the more likely to have an undecided attitude.

CONCLUSIONS:

Current use of therapeutic options is determined by medical condition in analogy to clinical guidelines. For future considerations, other factors such as cultural background are crucial, yielding hurdles to be regarded in the implementation of advanced directives in a multicultural environment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cross-Cultural Comparison / Decision Making / Amyotrophic Lateral Sclerosis Type of study: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Neurol Year: 2018 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cross-Cultural Comparison / Decision Making / Amyotrophic Lateral Sclerosis Type of study: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Neurol Year: 2018 Document type: Article Affiliation country: